INTRODUCTION
============

Linear IgA dermatosis (LAD) is a rare acquired autoimmune bullous disease of unknown etiology, unrelated to gluten-sensitive enteropathy, that affects both adults and children, being also known as chronic bullous dermatosis of childhood (CBDC) in the latter age group. Clinical manifestations are broad, ranging from urticarial, annular or polycyclic reddish patches to small clustered vesicles, tense blisters or large eroded areas. New vesicles may arise around healed blisters, giving rise to the \"cluster of jewels\" pattern. Mucosal involvement occurs in up to 80% of cases. ^[@B01]^ Histopathology reveals a sub-epidermal cleavage and a neutrophil-rich superficial dermal inflammatory infiltrate. In LAD, there is a tendency for neutrophils to be disposed singly along the basal layer of the epidermis, but dermal papilla microabscesses may be possibly found. ^[@B01]^ Actually there is a significant overlap between the histopathologic features of LAD, DH, bullous lupus erythematosus, some drug eruptions and rare forms of bullous pemphigoid. Direct immunofluorescense studies are therefore the goldstandard method for diagnosis of LAD, through visualization of the characteristic linear deposition of IgA along the dermoepidermal junction. We report a case of LAD associated with ulcerative colitis (UC), which was resistant to medical therapy and the patient underwent complete and sustained remission after total colectomy.

CASE REPORT
===========

A 13-year-old boy sought dermatological consultation because of itching skin lesions lasting one month. He had had UC diagnosed 11 months earlier and was in continuous use of adalimumab, mesalazine and prednisone (10mg/d). On physical examination, erosions with some peripherally disposed vesicles over a reddish background on the forehead and glabella were seen ([Figure 1](#f01){ref-type="fig"}). Some impetigo-like pustular lesions were found on the chin and around the nose. There was also oral involvement, some crusted clustered papules in the precordium, and some large erosions with hemorrhagic exudate in the back, lumbar region and buttocks ([Figures 2](#f02){ref-type="fig"} and [3](#f03){ref-type="fig"}). In the intergluteal region, a large eroded plaque covered by a whitish membrane was observed ([Figure 4](#f04){ref-type="fig"}). The patient denied use of any medication previously associated to drug induced-LAD such as vancomycin, penicillin, ceftriaxone, metronidazole, captopril, phenytoin, diclofenac, somatostatin, amiodarone, lithium, cefamandole, cyclosporin, interleukin-2, interferon-γ etc. ^[@B01]^ Histopathology revealed a subepidermal blister and a superficial inflammatory infiltrate consisting of neutrophils arranged in collections on dermal papillae ([Figures 5](#f05){ref-type="fig"} and [6](#f06){ref-type="fig"}). Direct immunofluorescense of perilesional skin depicted a strong linear deposition of IgA along the basement membrane and a focal granular positiveness of C3 (non-specific finding) ([Figure 7](#f07){ref-type="fig"}). IgG, IgM and fibrinogen were negative. The diagnosis of LAD was therefore established and treatment with dapsone 50 mg/day started. In two weeks there was regression of all the skin lesions, leaving only erosions inside the mouth, which were handled with triancinolone acetonide 0.1% ointment. At this point in time oral prednisone was suspended. One month later there was a relapse of perineal and intergluteal lesions, with bleeding. Oral prednisone was reinitiated in the dose of 20mg/day. A new attempt of tapering prednisone resulted again in a worsening of the skin lesions and the dose of dapsone was increased to 100mg/d. LAD remained partially but unsatisfactorily controlled over the next 2.5 months, when the patient underwent total colectomy with ileorectal anastomosis for UC and experienced a substantial improvement of skin lesions, allowing reduction of prednisone and dapsone to 10 mg and 50 mg every other day, respectively. After 3 months, the patient returned with complete remission of both LAD and UC and all medications were suspended. There was no relapse in two years of follow-up.
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DISCUSSION
==========

The association of LAD and inflammatory bowel diseases (IBDs) has been increasingly reported in the recent literature. The first case was reported in 1988, concerning a patient with Crohn\'s disease, and the association of LAD with UC was documented for the first time in 1992. ^[@B02],[@B03]^ In 1993, Handley et al reported a case of a 12-year-old boy with UC and LAD refratory to prednisone, cyclosporin and talidomide, who had been previously submitted to colectomy because of a toxic megacolon. He experienced complete remission of skin lesions after resection of the remaining diseased rectal stump.^[@B04]^ In a British cohort with 70 patients of LAD, concurrent UC was found in 5 patients (7.1%), although the estimated prevalence of UC in the United Kingdom is actually only 0.05%.^[@B05]^ We found 23 previously-reported cases of LAD associated with IBDs during our bibliographical research.^[@B02]-[@B17]^ In all but one case, IBD preceded LAD over periods ranging from a few weeks to 43 years. 12 The underlining IBD was UC in 20 cases and Crohn\'s disease in three. In two cases of UC, there was complete remission of LAD after total colectomy, and in a further two after ressection of the remaining diseased rectal stump in patients previously submitted to colectomy with rectum preservation. ^[@B04],[@B10],[@B11],[@B16]^ In three cases, LAD remained active after colectomy: two were indicated for treatment of colon adenocarcinoma and one because of toxic megacolon.^[@B05],[@B09]^ The rectum stump was preserved in one of these cases, but in the other two the surgery was not sufficiently detailed. In a single case, a close relationship between the activity of UC and LAD was documented, with healing of skin lesions in the event of Ulcerative Colitis Activity Index (UCAI) being under 180, and relapse when it was above 190. ^[@B15]^ The etiology and pathogenicity of the association between IBDs and LAD is still not completely clear. It is known that patients with UC have a higher number of IgA and IgG-producing lymphocytes in the colon mucosa. In vitro studies revealed that B-lymphocytes from bowel mucosa of UC patients produce less total IgA than controls, but secrete more monomeric IgA (specially IgA-1). ^[@B18],[@B19]^ LAD is a disease mediated by monomeric IgA-1.^[@B20]^ It is possible that the immunologic disturbance in patients of UC reflects an alteration in the process of antigenic presentation, resulting in an abnormal production of IgA-1 with cross-reactiveness to antigens of lamina lucida and sub-lamina densa in genetically susceptible patients. Despite the lack of populational studies calculating the relative risk of LAD in patients with UC, the available evidence strongly suggests a significant association, with UC playing an important role in the development of LAD. The present report is the fifth in which LAD abated after surgical treatment for UC, indicating that the colon/rectum might be the source of antigenic stimulation in these cases, driving the autoimmune response and leading to the production of immunoglobulins against normal self-peptides.
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